Rakesh Jhunjhunwala’s investment firm Rare Enterprises-backed IKS Health is set to file draft papers with the Securities and Exchange Board of India in September for floating initial public offering (IPO) soon, reports said. IKS Health is reportedly looking to raise ₹2,500 crore via the issuance of 15% equity. Rare Enterprises hold a nearly 54% stake in IKS Health.